Tag: drugs

Drug test

Bill Current on Post-Accident Drug Testing and Cannabis Legalization

On our latest episode of the EHS on Tap podcast, we discussed a persistent problem for occupational health and safety managers—post-accident drug testing. Read on for a transcript of our conversation with Bill Current, President of the Current Consulting Group and a 30-year veteran of the drug testing industry.

Semi trucks

FMCSA’s Clearinghouse Flags Nearly 8,000 Violations

Nearly 8,000 positive substance abuse tests of commercial drivers have been identified since the Federal Motor Carrier Safety Administration’s (FMCSA) Commercial Driver’s License Drug and Alcohol Clearinghouse rule became effective January 6, according to the Agency.

Drug test

FMCSA Raises Minimum Random Drug Testing Rate for Drivers

The Federal Motor Carrier Safety Administration (FMCSA) announced December 27, 2019, that it is doubling the minimum annual percentage rate of random drug testing for commercial motor vehicle (CMV) drivers. The agency is raising the minimum random drug testing rate of commercial driver’s license (CDL) holders from the current 25% to 50% for calendar year […]

Marijuana and opioids, drug use

How Can You Promote Safety in the ‘Stoned Age’?

Read the transcript of our recent EHS on Tap podcast wherein we talked with Nina M. French, Managing Partner for the Current Consulting Group, about the current trends in drug legalization, use, and abuse, and how EHS pros can effectively maintain a drug-free, safe, healthy, and productive workplace.

Marijuana and opioids, drug use

Employers See Effects of Rising Opioid, Marijuana Use

The use and misuse of both illicit and prescription drugs are affecting a growing number of employers. Whether marijuana or opiates are obtained legally or illegally, both are present in the workplace. An increasing number of workers are even dying on the job from drug and alcohol overdoses. The most acute hazards are faced by […]

ASCO Addresses Safe Handling of Hazardous Drugs

An American Society of Clinical Oncology (ASCO) panel began work on developing standards for the safe handling of hazardous drugs. The expert panel endorsed three sets of existing guidelines and standards. However, it also identified issues it felt existing standards did not adequately address.